Literature DB >> 14848726

Cortisone in treatment of bronchial asthma.

M S HARRIS.   

Abstract

Twenty patients with intractable asthma were treated with cortisone on various dosage schedules. Results indicated that a rapid improvement in the asthmatic state may be expected in four to five days with high level dosage of the hormone-usually a total dose exceeding 200 mg. per day at the beginning. If treatment is discontinued after a week, relapse usually will occur within a period of eight days. If small doses are given two or three times weekly, following initial response, relapse may not occur for 20 or 30 days. The interspersed administration of ACTH during an attempt to discontinue cortisone apparently was of no value. It therefore appears that cortisone control of intractable asthma is dependent on large dosage until clinical improvement is obtained, then approximately 100 mg. two or three times a week for maintenance of a reasonable state of health.

Entities:  

Keywords:  ASTHMA; CORTISONE

Mesh:

Substances:

Year:  1951        PMID: 14848726      PMCID: PMC1520983     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  3 in total

1.  Oral use of cortisone acetate.

Authors:  E W BOLAND; N E HEADLEY
Journal:  J Am Med Assoc       Date:  1951-01-06

2.  Physiological effects of cortisone and pituitary adrenocorticotropic hormone (ACTH) in man.

Authors:  R G SPRAGUE; M H POWER; H L MASON
Journal:  J Am Med Assoc       Date:  1950-12-16

3.  Effects of pituitary adrenocorticotropic hormone (ACTH) on the hypersensitive state.

Authors:  J E HOWARD; A M HARVEY; R A CAREY; W L WINKENWERDER
Journal:  J Am Med Assoc       Date:  1950-12-16
  3 in total
  1 in total

Review 1.  Modeling asthma: Pitfalls, promises, and the road ahead.

Authors:  Helene F Rosenberg; Kirk M Druey
Journal:  J Leukoc Biol       Date:  2018-02-16       Impact factor: 4.962

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.